comparemela.com

Latest Breaking News On - Hedge funds weigh in on tonix pharmaceuticals - Page 1 : comparemela.com

StockNews.com Initiates Coverage on Tonix Pharmaceuticals (NASDAQ:TNXP)

Equities researchers at StockNews.com assumed coverage on shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Get Free Report) in a report issued on Wednesday. The brokerage set a “sell” rating on the stock. Separately, Dawson James began coverage on shares of Tonix Pharmaceuticals in a report on Wednesday, February 28th. They set a “buy” rating and a […]

Zembrace-symtouch
Dawson-james
Tonix-pharmaceuticals-company-profile
News-ratings-for-tonix-pharmaceuticals-daily
Armistice-capital
Hedge-funds-weigh-in-on-tonix-pharmaceuticals
Sabby-management
Tonix-pharmaceuticals
Tonix-pharmaceuticals-holding-corp
Tonix-pharmaceuticals-price-performance
Acadian-asset-management
Get-free-report

Tonix Pharmaceuticals (NASDAQ:TNXP) Receives New Coverage from Analysts at StockNews.com

StockNews.com started coverage on shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Free Report) in a research report sent to investors on Sunday morning. The firm issued a sell rating on the stock. Separately, Dawson James started coverage on shares of Tonix Pharmaceuticals in a research report on Wednesday, February 28th. They set a buy rating and […]

Dawson-james
Zembrace-symtouch
Tonix-pharmaceuticals
Exchange-commission
Nasdaq
Hedge-funds-weigh-in-on-tonix-pharmaceuticals
Sabby-management
Tonix-pharmaceuticals-stock
News-ratings-for-tonix-pharmaceuticals-daily
Tonix-pharmaceuticals-holding-corp
Free-report
Get-free-report

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Sees Significant Increase in Short Interest

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP – Get Free Report) saw a significant growth in short interest during the month of March. As of March 15th, there was short interest totalling 967,000 shares, a growth of 56.9% from the February 29th total of 616,200 shares. Approximately 1.2% of the shares of the company are short sold. […]

Zembrace-symtouch
Dawson-james
Renaissance-technologies
Geode-capital-management
Tonix-pharmaceuticals-holding-corp
Tonix-pharmaceuticals-trading-down
Virtu-financial
Nasdaq
News-ratings-for-tonix-pharmaceuticals-daily
Tonix-pharmaceuticals
Hedge-funds-weigh-in-on-tonix-pharmaceuticals
Tonix-pharmaceuticals-company-profile

Tonix Pharmaceuticals (NASDAQ:TNXP) Earns Sell Rating from Analysts at StockNews.com

StockNews.com began coverage on shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Free Report) in a research note issued to investors on Tuesday morning. The firm issued a sell rating on the stock. Separately, Dawson James assumed coverage on Tonix Pharmaceuticals in a report on Wednesday, February 28th. They set a buy rating and a $3.00 target […]

Dawson-james
Zembrace-symtouch
Tonix-pharmaceuticals-holding-corp
Jpmorgan-chase-co
Tonix-pharmaceuticals-price-performance
News-ratings-for-tonix-pharmaceuticals-daily
Hedge-funds-weigh-in-on-tonix-pharmaceuticals
Raymond-james-associates
Tonix-pharmaceuticals
Virtu-financial
Free-report
Sigma-investments

Tonix Pharmaceuticals (NASDAQ:TNXP) Now Covered by Analysts at StockNews.com

Tonix Pharmaceuticals (NASDAQ:TNXP) Now Covered by Analysts at StockNews.com
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Zembrace-symtouch
Virtu-financial
Tonix-pharmaceuticals-holding-corp
Hedge-funds-weigh-in-on-tonix-pharmaceuticals
Renaissance-technologies
Tonix-pharmaceuticals
News-ratings-for-tonix-pharmaceuticals-daily
Nasdaq
Tonix-pharmaceuticals-stock-down
Tonix-pharmaceuticals-company-profile
Geode-capital-management
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.